These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy. Borovskaja TG; Sergeeva SA; Udut VV; Fomina TI; Jurmazov ZA; Pahomova AV; Poluektova ME; Chemerova JA; Rumpel' OA Bull Exp Biol Med; 2011 Sep; 151(5):588-92. PubMed ID: 22462052 [TBL] [Abstract][Full Text] [Related]
6. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia. Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993 [TBL] [Abstract][Full Text] [Related]
8. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis. El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats. Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334 [TBL] [Abstract][Full Text] [Related]
10. [Effect of biologically active substances of animal and plant origin on prooxidant-antioxidant balance in rats with experimental prostatic hyperplasia]. Belostotskaia LI; Nikitchenko IuV; Gomon ON; Chaĭka LA; Bondar' VV; Dziuba VN Eksp Klin Farmakol; 2006; 69(4):66-8. PubMed ID: 16995443 [TBL] [Abstract][Full Text] [Related]
11. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate. Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033 [TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen/androgen induced rat benign prostatic hyperplasia model in vivo. Huang JJ; Cai Y; Yi YZ; Huang MY; Zhu L; He F; Liu XW; Huang BY; Yuan M Eur J Pharmacol; 2016 Nov; 791():473-481. PubMed ID: 27615445 [TBL] [Abstract][Full Text] [Related]
14. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage. Rick FG; Szalontay L; Schally AV; Block NL; Nadji M; Szepeshazi K; Vidaurre I; Zarandi M; Kovacs M; Rekasi Z J Urol; 2012 Apr; 187(4):1498-504. PubMed ID: 22341819 [TBL] [Abstract][Full Text] [Related]
15. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats. Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629 [TBL] [Abstract][Full Text] [Related]
16. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats. Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of pharmacological activity of afala on the model of hormone-induced prostatitis in rats. Savelieva KV; Borovskaya TG; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI Bull Exp Biol Med; 2007 Nov; 144(5):699-701. PubMed ID: 18683500 [TBL] [Abstract][Full Text] [Related]
18. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats. Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia. Borovskaya TG; Fomina TI; Ermolaeva LA; Vychuzhanina AV; Pakhomova AV; Poluektova ME; Shchemerova YA Bull Exp Biol Med; 2013 May; 155(1):67-70. PubMed ID: 23667874 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory Activities of Phenolic Compounds Isolated from Adina rubella Leaves Against 5α-Reductase Associated with Benign Prostatic Hypertrophy. Yin J; Heo JH; Hwang YJ; Le TT; Lee MW Molecules; 2016 Jul; 21(7):. PubMed ID: 27399661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]